Noh Y et al
Monitor Your Progress Track your weekly weight, fasting blood glucose (if treating type 2 diabetes), and any side effects in a simple log
In SURMOUNT-1, published in NEJM in 2022, tirzepatide at the 15 mg weekly dose produced a mean placebo-adjusted body weight reduction of 17.8% at 72 weeks in adults with obesity (Jastreboff et al., NEJM, 2022)
Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial
We call it pre-juvenation, where you start the rejuvenating process before you see it. Interested in learning more about weight loss drugs and how to safely offer them to your medical spa clients
The solution should be clear